|
Department of Health and Human Services
National Institutes of Health
National Institute on Drug Abuse
100th Meeting
National Advisory Council on Drug Abuse
Neuroscience Center - Conference Room C
6001 Executive Boulevard, Bethesda, MD.
September 9, 2008
Closed Session
This meeting is closed to the public in accordance with the provisions set forth in section 552b{c} and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).
| 2:00 p.m. |
Call to Order
Timothy P. Condon, Ph.D., Deputy Director, NIDA
Review and Policy Procedures
Teresa Levitin, Ph.D., Executive Secretary,
National Advisory Council on Drug Abuse
Council Review of Grant Applications
Timothy P. Condon, Ph.D., Deputy Director, NIDA
Division of Pharmacotherapies and Medical Consequences of Drug Abuse
Frank Vocci, Ph.D., Director
Office of Science Policy and Communications
Lucinda Miner, Ph.D., Deputy Director
Division of Basic Neuroscience and Behavioral Research
David Shurtleff, Ph.D., Director
Division of Clinical Neuroscience and Behavioral Research
Joseph Frascella, Ph.D., Director
Division of Epidemiology, Services and Prevention Research
Wilson Compton, M.D., M.P.E., Director
|
| 5:00 p.m. |
Adjournment |
September 10, 2008
Open Session
| 8:00 - 8:15 a.m. |
Opening and Welcome
Nora Volkow, M.D., Director, NIDA |
| 8:15 - 9:15 a.m. |
Director's Report
Nora Volkow, M.D.
Director, NIDA |
| 9:15 - 9:45 a.m. |
Council Discussion |
|
| 9:45 - 10:00 a.m. |
Public Comments |
|
| 10:00 a.m. |
Adjourn |
| 10:30 a.m. |
Council members board buses for Intramural Research Program tour and presentations in Baltimore |
|
|
|
